Recommendations of the U.S. Public Health Service Task Force on the Use of Zidovudine to Reduce Perinatal Transmission of Human Immuno deficiency Virus

The MMWR series of publications is published by the Epidemiology Program Office,
Centers for Disease Control and Prevention (CDC), Public Health Service, U.S. Department of Health and Human Services, Atlanta, GA 30333.
SUGGESTED CITATION
Centers for Disease Control and Prevention. Recommendations for the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus.
MMWR 1994;43(No. RR-11):[inclusive page numbers].
Centers for Disease Control and Prevention.............David Satcher, M.D., Ph.D.
Director
James W. Curran, M.D., M.RH.
Associate Director for HIV/AIDS
The production of this report as an MMWR serial publication was coordinated in:
Epidemiology Program Office................Stephen B. Thacker, M.D., M.Sc.
Director
Richard A. Goodman, M.D., M.RH.
Editor, MMWR Series
Scientific Information and Communications Program
Recommendations and Reports...............Suzanne M. Hewitt, M.P.A.
Managing Editor
Ava W. Navin, M.A.
Project Editor
Rachel J. Wilson
Writer-Editor
Peter M. Jenkins
Visual Information Specialist
These recommendations do not represent approval by the Food and Drug Administration (FDA) or approved labeling for the particular product or indications in
question.
Use of trade names is for identification only and does not imply endorsement by
the Public Health Service or the U.S. Department of Health and Human Services.